
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Nattokinase is a potent serine protease enzyme derived from *Bacillus subtilis natto* during the fermentation of soybeans, primarily recognized for its strong fibrinolytic (clot-dissolving) activity. It directly hydrolyzes fibrin, a key component of blood clots, and enhances the body's natural thrombolytic processes to improve cardiovascular health.

Reported Benefits (Provisional)
Origin & History

Nattokinase is a potent serine proteolytic enzyme (EC 3.4.21.x) derived from *Bacillus subtilis natto*, the bacterium responsible for fermenting soybeans into the traditional Japanese food, natto. Renowned for its significant fibrinolytic activity, nattokinase supports healthy blood circulation and reduces the risk of blood clot formation. It is widely utilized in supplements for its natural therapeutic properties in cardiovascular health.
Research Narrative (Provisional)
Extensive in vitro, animal, and human clinical trials, including randomized controlled studies, have investigated nattokinase's fibrinolytic, anti-hypertensive, and anti-platelet aggregation effects. Research supports its potential in reducing blood clot formation, improving blood flow, and contributing to healthy blood pressure levels, establishing its role in cardiovascular health.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Serine proteolytic enzyme (EC 3.4.21.x) - Specific activity: Fibrinolytic (hydrolyzes fibrin, fibrinogen, and plasminogen activator inhibitor-1) - Units of activity: Fibrinolytic Units (FU)
Reported Mechanism (Provisional)
Nattokinase (NK) primarily acts by directly hydrolyzing fibrin, the main protein component of blood clots. Additionally, it enhances the body's intrinsic fibrinolytic system by cleaving plasmin substrate, activating pro-urokinase to urokinase, increasing tissue plasminogen activator (t-PA), and degrading plasminogen activator inhibitor-1 (PAI-1). These combined actions significantly enhance overall thrombolytic activity, promoting better blood flow.
Clinical Narrative (Provisional)
Extensive research, including in vitro, animal, and human clinical trials—some being randomized controlled studies—has investigated nattokinase's effects. These studies have consistently demonstrated its fibrinolytic, anti-hypertensive, and anti-platelet aggregation properties. Outcomes suggest nattokinase's potential in reducing blood clot formation, improving blood flow, and contributing to healthy blood pressure regulation, supporting its role in cardiovascular health.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







